Yeung, Godfrey (2002) The implications of WTO accession on the pharmaceutical industry in China. Journal of Contemporary China, 11 (32). pp. 473-493. ISSN 1067-0564Full text not available from this repository.
Given the limited capabilities of R&D and global distribution channels, and the virtual non-existence of patented drugs, the Chinese pharmaceutical industry has little chance to enter the global market of Western prescription drugs and compete with the established global giants head-on. The reality is that they are chasing a moving target and their competitors are becoming bigger and stronger day by day. The substantial reduction of import tariffs and the granting of comprehensive trading and distribution rights to foreign-financed firms following WTO accession, effectively tilted the level-playing field against the Chinese pharmaceutical industry. Given the short-term competitive advantages of the Chinese pharmaceutical industry on Chinese drugs, three development strategies are suggested: (1) consolidate the local market of herbal and generic drugs; (2) market Chinese drugs via the Internet; and (3) outsource R&D and collaborative marketing.
|Schools and Departments:||School of Global Studies > Geography|
|Subjects:||G Geography. Anthropology. Recreation > G Geography (General) > G0001 Geography (General)|
|Depositing User:||Godfrey Yeung|
|Date Deposited:||06 Feb 2012 15:18|
|Last Modified:||14 Sep 2012 09:01|